Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

PURPOSE: Our purpose was to investigate the feasibility of pharmacy-initiated pharmacogenetic (PGt) screening in primary care with respect to patient willingness to participate, quality of DNA collection with saliva kits, genotyping, and dispensing data retrieved from the pharmacy. METHODS: Polyphar...

Descripción completa

Detalles Bibliográficos
Autores principales: Swen, J. J., van der Straaten, T., Wessels, J. A. M., Bouvy, M. L., Vlassak, E. E. W., Assendelft, W. J. J., Guchelaar, H.-J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Pharmacogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303061/
https://www.ncbi.nlm.nih.gov/pubmed/21984116
http://dx.doi.org/10.1007/s00228-011-1130-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303061/
https://www.ncbi.nlm.nih.gov/pubmed/21984116
http://dx.doi.org/10.1007/s00228-011-1130-4

Ejemplares similares